What You Always Wanted to Know About Gastric MALT-lymphoma: a Focus on Recent Developments

Overview

Journal Ther Adv Med Oncol

Specialty Oncology

Date 2021 Oct 8

PMID 34621332

Citations 7

Authors

Markus Raderer

Barbara Kiesewetter

Affiliations

Soon will be listed here.

Abstract

The stomach is the most common site of origin for extranodal lymphomas, with extranodal marginal zone B-cell of the mucosa associated lymphoid tissue (MALT-lymphoma) being the predominant subtype. MALT-lymphoma develops in mucosa associated lymphoid structures acquired by infection or chronic antigenic stimuli and may therefore arise in almost any organ of the human body. In spite of histopathologic similarities between various organs upon first glance, recent findings suggest pronounced differences between different sites, with a variety of features specific to gastric MALT-lymphoma. The objective of this review is to sum up the current knowledge on pathogenesis, molecular pathology, clinical presentation and therapeutic approaches to gastric MALT-lymphoma with in-depth discussion of recent developments.

Citing Articles

Primary MALT lymphoma of the breast: pathological and radiological characteristics.

Shibahara Y, Delabie J, Kulkarni S, Grant A, Prica A, McCready D Breast Cancer Res Treat. 2024; 205(2):387-394.

PMID: 38427311 DOI: 10.1007/s10549-024-07258-1.

Diagnostic and therapeutic recommendations on infection. Recommendations of the Working Group of the Polish Society of Gastroenterology.

Jaron K, Pietrzak A, Daniluk J, Adrych K, Gasiorowska A, Skrzydlo-Radomanska B Prz Gastroenterol. 2023; 18(3):225-248.

PMID: 37937106 PMC: 10626381. DOI: 10.5114/pg.2023.131998.

Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist's Point of View.

Matysiak-Budnik T, Priadko K, Bossard C, Chapelle N, Ruskone-Fourmestraux A Cancers (Basel). 2023; 15(15).

PMID: 37568627 PMC: 10417821. DOI: 10.3390/cancers15153811.

Helicobacter pylori-negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: A clinicopathologic analysis.

Gu S, Siddon A, Huntington S, Jain D Am J Clin Pathol. 2023; 160(6):612-619.

PMID: 37556379 PMC: 10691190. DOI: 10.1093/ajcp/aqad088.

An Overview of Selected Bacterial Infections in Cancer, Their Virulence Factors, and Some Aspects of Infection Management.

Ray A, Moore T, Pandit R, Burke A, Borsch D Biology (Basel). 2023; 12(7).

PMID: 37508393 PMC: 10376897. DOI: 10.3390/biology12070963.

References

Koch P, Probst A, Berdel W, Willich N, Reinartz G, Brockmann J . Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005; 23(28):7050-9. DOI: 10.1200/JCO.2005.04.031. View

Moody S, Thompson J, Chuang S, Liu H, Raderer M, Vassiliou G . Novel and mutation and distinct genetic profiles in MALT lymphomas of different sites. Haematologica. 2018; 103(8):1329-1336. PMC: 6068028. DOI: 10.3324/haematol.2018.191601. View

Wotherspoon A, Doglioni C, Diss T, Pan L, Moschini A, de Boni M . Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993; 342(8871):575-7. DOI: 10.1016/0140-6736(93)91409-f. View

Troch M, Puspok A, Streubel B, Chott A, Raderer M . Second complete remission of Helicobacter pylori negative gastric MALT lymphoma following antibiotic treatment. Leuk Lymphoma. 2007; 48(1):204-6. DOI: 10.1080/10428190601016142. View

Teckie S, Qi S, Lovie S, Navarrett S, Hsu M, Noy A . Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent. Int J Radiat Oncol Biol Phys. 2015; 92(1):130-7. DOI: 10.1016/j.ijrobp.2015.01.040. View

Kiesewetter B, Ferreri A, Raderer M . Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature. Oncologist. 2015; 20(8):915-25. PMC: 4524756. DOI: 10.1634/theoncologist.2015-0109. View

Mayerhoefer M, Jaeger U, Staber P, Raderer M, Wadsak W, Pfaff S . [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results. Invest Radiol. 2018; 53(7):403-408. DOI: 10.1097/RLI.0000000000000469. View

Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M . Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2011; 61(4):507-13. DOI: 10.1136/gutjnl-2011-300495. View

Du M, Diss T, Dogan A, Ye H, Aiello A, Wotherspoon A . Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa. J Pathol. 2000; 192(4):488-93. DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH727>3.0.CO;2-J. View

10.

Gong E, Ahn J, Jung H, Jung K, Cho C, Na H . Bone marrow involvement is not associated with the clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma. Scand J Gastroenterol. 2016; 51(8):942-8. DOI: 10.3109/00365521.2016.1151929. View

11.

Kiesewetter B, Raderer M . Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma). Hematol Oncol. 2020; 38(4):417-424. DOI: 10.1002/hon.2754. View

12.

Raderer M, Valencak J, Pfeffel F, Drach J, Pangerl T, Kurtaran A . Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type. J Natl Cancer Inst. 1999; 91(8):716-8. DOI: 10.1093/jnci/91.8.716. View

13.

Munari F, Lonardi S, Cassatella M, Doglioni C, Cangi M, Amedei A . Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood. 2011; 117(24):6612-6. DOI: 10.1182/blood-2010-06-293266. View

14.

Du M, Xu C, Diss T, Peng H, Wotherspoon A, Isaacson P . Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. Blood. 1996; 88(12):4445-51. View

15.

Megraud F, Floch P, Labenz J, Lehours P . Diagnostic of Helicobacter pylori infection. Helicobacter. 2016; 21 Suppl 1:8-13. DOI: 10.1111/hel.12333. View

16.

Raderer M, Kiesewetter B, Ferreri A . Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin. 2016; 66(2):153-71. DOI: 10.3322/caac.21330. View

17.

Salar A, Domingo-Domenech E, Panizo C, Nicolas C, Bargay J, Muntanola A . First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2016; 1(3):e104-11. DOI: 10.1016/S2352-3026(14)00021-0. View

18.

Wotherspoon A, Ortiz-Hidalgo C, Falzon M, Isaacson P . Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991; 338(8776):1175-6. DOI: 10.1016/0140-6736(91)92035-z. View

19.

Fischbach W, Goebeler M, Ruskone-Fourmestraux A, Wundisch T, Neubauer A, Raderer M . Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut. 2007; 56(12):1685-7. PMC: 2095715. DOI: 10.1136/gut.2006.096420. View

20.

Dogan A, Du M, Koulis A, Briskin M, Isaacson P . Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1997; 151(5):1361-9. PMC: 1858078. View